520880 港股通创新药ETF华宝
已收盘 11-13 15:00:00
资讯
新帖
简况
【ETF动向】11月9日港股通创新药ETF华宝基金涨0.95%,份额减少9000万份
证券之星 · 11-10
【ETF动向】11月9日港股通创新药ETF华宝基金涨0.95%,份额减少9000万份
【ETF动向】11月6日港股通创新药ETF华宝基金跌1.17%,份额减少9000万份
证券之星 · 11-07
【ETF动向】11月6日港股通创新药ETF华宝基金跌1.17%,份额减少9000万份
港股医药再突围!百济神州绩前领跑6%,CXO龙头反攻!创新药链核心工具520880、159137标的指数逆市涨逾2%
新浪基金 · 11-04
港股医药再突围!百济神州绩前领跑6%,CXO龙头反攻!创新药链核心工具520880、159137标的指数逆市涨逾2%
【ETF动向】10月27日港股通创新药ETF华宝基金跌4.39%,份额增加2.14亿份
证券之星 · 10-28
【ETF动向】10月27日港股通创新药ETF华宝基金跌4.39%,份额增加2.14亿份
什么情况?映恩生物-B狂泻30%创历史新低!港股通创新药普跌,520880标的指数跌逾3%
新浪基金 · 10-27
什么情况?映恩生物-B狂泻30%创历史新低!港股通创新药普跌,520880标的指数跌逾3%
港股通创新药急转直下,发生了什么?520880标的指数跌逾4.6%,再鼎医药、康方生物重挫
新浪基金 · 10-22
港股通创新药急转直下,发生了什么?520880标的指数跌逾4.6%,再鼎医药、康方生物重挫
港股通创新药继续向上,mRNA赛道领涨,520880标的指数上探3%!脑机接口国际标准发布,概念股一度暴拉22%
新浪基金 · 10-21
港股通创新药继续向上,mRNA赛道领涨,520880标的指数上探3%!脑机接口国际标准发布,概念股一度暴拉22%
港股通创新药止跌向上,520880标的指数摸高4.7%!药明康德尾盘突发跳水,发生了什么?
新浪基金 · 10-16
港股通创新药止跌向上,520880标的指数摸高4.7%!药明康德尾盘突发跳水,发生了什么?
跌到位了?创新药逆市活跃,药ETF(562050)成功收红,港股通创新药ETF华宝跑赢大市!ESMO大会下周启幕
新浪基金 · 10-15
跌到位了?创新药逆市活跃,药ETF(562050)成功收红,港股通创新药ETF华宝跑赢大市!ESMO大会下周启幕
【ETF动向】10月14日港股通创新药ETF华宝基金跌3.01%,份额增加5200万份
证券之星 · 10-15
【ETF动向】10月14日港股通创新药ETF华宝基金跌3.01%,份额增加5200万份
ETF午评|上证指数涨0.01%,消费板块走强,影视ETF、港股通互联网ETF涨3%,港股通创新药ETF再跌2%
格隆汇 · 10-14
ETF午评|上证指数涨0.01%,消费板块走强,影视ETF、港股通互联网ETF涨3%,港股通创新药ETF再跌2%
多重利好持续发酵,创新药攻势再起!场内热门标的520880、159137逆市上扬
新浪基金 · 09-23
多重利好持续发酵,创新药攻势再起!场内热门标的520880、159137逆市上扬
ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%
格隆汇 · 09-21
ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%
调仓提示!华宝基金港股通创新药ETF(520880)成份股“5进3出”,复宏汉霖等多只新入通标的获纳入
新浪基金 · 09-15
调仓提示!华宝基金港股通创新药ETF(520880)成份股“5进3出”,复宏汉霖等多只新入通标的获纳入
创新药跌跌不休,什么原因?华宝基金港股通创新药ETF(520880)失守所有均线
新浪基金 · 09-13
创新药跌跌不休,什么原因?华宝基金港股通创新药ETF(520880)失守所有均线
重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线
新浪基金 · 09-11
重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
新浪基金 · 09-03
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份
证券之星 · 08-28
【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份
创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!
新浪基金 · 08-27
创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!
【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份
证券之星 · 08-26
【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份
暂无数据
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"520880","market":"SH","secType":"STK","nameCN":"港股通创新药ETF华宝","latestPrice":0.414,"timestamp":1794553200000,"preClose":0.425,"halted":0,"volume":677331400,"delay":0,"changeRate":-0.0259,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.011,"latestTime":"11-13 15:00:00","open":0.422,"high":0.423,"low":0.412,"amount":283000000,"amplitude":0.0259,"askPrice":0.414,"askSize":35181,"bidPrice":0.413,"bidSize":34506,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":0.425,"symbolType":"fund","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":0.468,"lowLimit":0.383,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.138091,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/520880/tweets","defaultTab":"tweets","newsList":[{"id":"2682337218","title":"【ETF动向】11月9日港股通创新药ETF华宝基金涨0.95%,份额减少9000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2682337218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682337218?lang=zh_cn&edition=full","pubTime":"2026-11-10 06:46","pubTimestamp":1794264396,"startTime":"0","endTime":"0","summary":"证券之星消息,11月9日,港股通创新药ETF华宝基金(520880)涨0.95%,成交额3.5亿元。当日份额减少了9000万份,最新份额为44.46亿份,近20个交易日份额增加1.2亿份。当日资金净流出1651.15万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为19.13亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.68%,近一个月超额回报为0.26%,管理人为华宝基金公司,基金经理为丰晨成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000008782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681970858","title":"【ETF动向】11月6日港股通创新药ETF华宝基金跌1.17%,份额减少9000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2681970858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681970858?lang=zh_cn&edition=full","pubTime":"2026-11-07 06:49","pubTimestamp":1794005366,"startTime":"0","endTime":"0","summary":"证券之星消息,11月6日,港股通创新药ETF华宝基金(520880)跌1.17%,成交额3.52亿元。当日份额减少了9000万份,最新份额为45.36亿份,近20个交易日份额增加2.26亿份。当日资金净流出6789.9万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为19.3亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.63%,近一个月超额回报为0.22%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700008483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680074627","title":"港股医药再突围!百济神州绩前领跑6%,CXO龙头反攻!创新药链核心工具520880、159137标的指数逆市涨逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680074627","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680074627?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:17","pubTimestamp":1793758620,"startTime":"0","endTime":"0","summary":"创新药及产业链全线拉涨:创新药龙头股领衔涨势,百济神州一度领涨超6%,荣昌生物、康方生物涨超4%;CXO同样强势,凯莱英涨近7%,药明生物、药明康德双双涨超4%。创新药纯度100%的恒生港股通创新药精选指数、高CXO含量港股通医疗主题指数携手涨超2%,跟踪指数的港股通创新药ETF华宝、港股通医疗ETF华宝同步走强。港股通创新药ETF华宝、港股通医疗ETF华宝标的指数市盈率估值分别为29.86倍、31倍,处于近3年维度16.67%、50%分位点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-11-04/doc-inixprpe1740509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK1574","159718","159992","LU2328871848.SGD","CXO","LU1770034418.SGD","06160","LU0828237510.HKD","LU0588546209.SGD","BK4585","LU1251922891.USD","159137","BK1583","BK1588","LNGR","IBBQ","520880","LU0307460666.USD","BK1161","KURE","ONC","BK4526","06978","LU0228659784.USD","LU1303224171.USD","MEDX","BK4139","688235","LU1719994722.HKD","LU1969619763.USD","BK1500","BK0239","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678484103","title":"【ETF动向】10月27日港股通创新药ETF华宝基金跌4.39%,份额增加2.14亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2678484103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678484103?lang=zh_cn&edition=full","pubTime":"2026-10-28 06:33","pubTimestamp":1793140406,"startTime":"0","endTime":"0","summary":"证券之星消息,10月27日,港股通创新药ETF华宝基金(520880)跌4.39%,成交额4.07亿元。当日份额增加了2.14亿份,最新份额为47.16亿份,近20个交易日份额增加3.62亿份。当日资金净流入1316.83万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为18.67亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.42%,近一个月超额回报为0.01%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800008287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678149542","title":"什么情况?映恩生物-B狂泻30%创历史新低!港股通创新药普跌,520880标的指数跌逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678149542","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678149542?lang=zh_cn&edition=full","pubTime":"2026-10-27 10:46","pubTimestamp":1793069160,"startTime":"0","endTime":"0","summary":"10月27日,港股高开低走,创新药继续下行,港股通创新药ETF华宝标的指数跌超3%再创3个月新低。两只成份股突发大跌:映恩生物-B盘中一度跌30%创历史新低,康诺亚-B一度挫逾15%。直接诱因或来自ESMO大会数据成色。临床价值低于市场预期的叠加,触发了今日的估值重新定价。逢跌布局创新药,关注T+0“利器”——港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,近7成仓位押注创新药研发龙头。权重数据截至2026.9.30。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-27/doc-iniwrqsx4745221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06978","HK0000252160.HKD","LNGR","MEDX","HK0000500386.USD","LU2543165471.USD","BK1574","HK0000252152.HKD","09606","159992","IBBQ","520880","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677873639","title":"港股通创新药急转直下,发生了什么?520880标的指数跌逾4.6%,再鼎医药、康方生物重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2677873639","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677873639?lang=zh_cn&edition=full","pubTime":"2026-10-22 11:01","pubTimestamp":1792638060,"startTime":"0","endTime":"0","summary":"10月22日,港股通创新药修复戛然而止,行情急转直下,港股通创新药ETF华宝标的指数下挫逾4.6%,失守所有均线。最新数据显示,截至最新,港股通创新药ETF华宝标的指数市盈率TTM为33.93倍,已回落至近3年39%分位点,配置性价比凸显。低位吸纳港股通创新药核心资产,关注T+0交易工具——港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,近7成仓位押注创新药研发龙头。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-22/doc-iniwaezr5258400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FLHK","LU2488822045.USD","LU2476274308.USD","LU0348766576.USD","LU0348767384.USD","LU1794554557.SGD","06978","LU0348825331.USD","MEDX","LU0540923850.HKD","IE00BPRC5H50.USD","BK4139","BK1161","LU0348783233.USD","LU0348784397.USD","LU0634319403.HKD","BK4526","LNGR","BK4588","ZLAB","IE00B543WZ88.USD","LU1961090484.USD","LU0348827113.USD","09926","LU0417516571.SGD","BK1574","LU0561508036.HKD","BK1588","LU2476274720.SGD","09688","IBBQ","LU0348735423.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU0417516738.SGD","LU0417516902.SGD","159992","LU1720050803.USD","BK4548","LU2399975544.HKD","520880","BK4585","BK4531","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677564695","title":"港股通创新药继续向上,mRNA赛道领涨,520880标的指数上探3%!脑机接口国际标准发布,概念股一度暴拉22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677564695","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677564695?lang=zh_cn&edition=full","pubTime":"2026-10-21 10:37","pubTimestamp":1792550220,"startTime":"0","endTime":"0","summary":"10月21日,港股医药继续向上!mRNA赛道创新药企表现强势,云顶新耀涨超6%,康希诺生物、再鼎医药等多股涨超5%,恒生港股通创新药精选指数盘初上探3%,现涨超2%收复半年线,跟踪指数的港股通创新药ETF华宝走出四连涨。全链布局创新药,可关注两个T+0交易工具:港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,近7成仓位押注创新药研发龙头。港股通医疗ETF华宝:标的指数重仓创新药产业链,AI制药含量超73%,CXO含量近60%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-21/doc-inivyaat6192154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","MNTL","IBRN","520880","BK1161","159992","FLHK","06978","MEDX","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675591212","title":"港股通创新药止跌向上,520880标的指数摸高4.7%!药明康德尾盘突发跳水,发生了什么?","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591212","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591212?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:57","pubTimestamp":1792151820,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。早盘创新药全链反攻,港股通创新药ETF华宝、港股通医疗ETF华宝标的指数分别上探4.7%、3.9%,午后受药明系突发跳水影响涨幅收窄,但最终仍各自收涨1.94%、0.19%。捕捉港股医药高弹性机遇,关注两个T+0交易工具:港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,7成仓位押注创新药研发龙头。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-16/doc-inivmpqz6915860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","IBBQ","LU1997245177.USD","BK1161","IE00B543WZ88.USD","LU1979443071.USD","LU0072913022.USD","BK1576","LNGR","BK1583","LU0456842615.SGD","LU0106959298.USD","LU0469268626.HKD","LU1251922891.USD","FLHK","LU0700851271.USD","LU1997245094.SGD","LU1808992512.USD","LU1770034418.SGD","BK1141","LU2045819591.USD","LU0708995583.HKD","159992","BK1574","MEDX","LU0052750758.USD","BK0216","LU1303224171.USD","IE00BPRC5H50.USD","LU0348767384.USD","LU0327786744.USD","LU0348766576.USD","LU2328871848.SGD","LU1934453819.USD","520880","LU0611395673.USD","02359","LU0320764599.SGD","IE00B5MMRT66.SGD","LU1046422090.SGD","LU1997244956.HKD","LU2495084118.USD","LU0572944931.SGD","LU1969619763.USD","06978","603259","LU0501845795.SGD","LU2242644610.SGD","LU1719994722.HKD","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675758139","title":"跌到位了?创新药逆市活跃,药ETF(562050)成功收红,港股通创新药ETF华宝跑赢大市!ESMO大会下周启幕","url":"https://stock-news.laohu8.com/highlight/detail?id=2675758139","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675758139?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:33","pubTimestamp":1792063980,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。10月15日,大市深度调整,A+H创新药资产逆市活跃,带动药ETF华宝成功收红,港股通创新药ETF华宝标的指数微跌0.4%跑赢大市。截至收盘,港股通创新药ETF华宝标的指数走出7连跌,盘中点位创近3个月新低。图:港股通创新药ETF华宝近6月日K走势今日板块未能全面上涨,主要受美联储加息预期升温压制。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-15/doc-iniviekf8076114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","BK4588","BK4550","MEDX","562050","520880","06978","FDN","LNGR","BK4585","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675554378","title":"【ETF动向】10月14日港股通创新药ETF华宝基金跌3.01%,份额增加5200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675554378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675554378?lang=zh_cn&edition=full","pubTime":"2026-10-15 06:33","pubTimestamp":1792017191,"startTime":"0","endTime":"0","summary":"证券之星消息,10月14日,港股通创新药ETF华宝基金(520880)跌3.01%,成交额2.73亿元。当日份额增加了5200万份,最新份额为45.42亿份,近20个交易日份额增加1.78亿份。当日资金净流出4640.74万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为19.07亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.86%,近一个月超额回报为-0.23%,管理人为华宝基金公司,基金经理为丰晨成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500004715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675392762","title":"ETF午评|上证指数涨0.01%,消费板块走强,影视ETF、港股通互联网ETF涨3%,港股通创新药ETF再跌2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392762","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675392762?lang=zh_cn&edition=full","pubTime":"2026-10-14 11:38","pubTimestamp":1791949119,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159619","LU1655091616.SGD","BK0183","BK0188","BK0028","LU0067412154.USD","BK0201","513040","LU0072913022.USD","BK0012","BK0187","LU1993786604.SGD","LU0501845795.SGD","159855","LU1226287529.USD","IE00B0JY6N72.USD","LU1781817850.SGD","513220","LU0880133367.SGD","LU1807302812.USD","000001","BK0278","LU1580142542.USD","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669210892","title":"多重利好持续发酵,创新药攻势再起!场内热门标的520880、159137逆市上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=2669210892","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669210892?lang=zh_cn&edition=full","pubTime":"2026-09-23 14:31","pubTimestamp":1790145060,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝逆市飘红。AI制药含量、CXO含量双高的港股通医疗ETF华宝逆市走强。政策端,创新药产业再获国家级战略背书。港股通创新药ETF华宝覆盖的50家创新药研发公司中,34家上半年实现盈利,归母净利同比正增长的有36家,占比超7成。全链布局创新药,可关注两个T+0交易工具:港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,7成仓位押注创新药研发龙头。权重数据截至2026.8.31。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-23/doc-inisuxhc8551792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","LNGR","MEDX","BK1161","IBBQ","159137","520880","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348701","title":"ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348701","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669348701?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:36","pubTimestamp":1789961790,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["520880","513120","159316","520500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641935","title":"调仓提示!华宝基金港股通创新药ETF(520880)成份股“5进3出”,复宏汉霖等多只新入通标的获纳入","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641935","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667641935?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:10","pubTimestamp":1789470600,"startTime":"0","endTime":"0","summary":"9月14日,100%布局创新药研发龙头的恒生港股通创新药精选指数季度调整正式生效,被动跟踪该指数的港股通创新药ETF华宝同步调仓换血。成份股“5进3出”,总数回升至50只。港股通创新药ETF华宝标的指数相较同类指数率先导入“新鲜血液”:此次调入的5只成份股中,复宏汉霖、和铂医药-B、基石药业-B、瑞博生物-B等4只均为9月7日新纳入港股通的标的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-15/doc-inirxhzq8479614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HK0000165453.HKD","159316","520880","HK0000320223.HKD","HK0000306685.HKD","HK0000306701.USD","HK0000320264.USD","02696","FLHK","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667684274","title":"创新药跌跌不休,什么原因?华宝基金港股通创新药ETF(520880)失守所有均线","url":"https://stock-news.laohu8.com/highlight/detail?id=2667684274","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667684274?lang=zh_cn&edition=full","pubTime":"2026-09-13 19:25","pubTimestamp":1789298700,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线,重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图:港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整?低位埋伏创新药,关注两大投资工具:港股通创新药ETF华宝:紧密跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,前十大权重股占比超七成,龙头属性突出,底层资产是港股,高弹性、T+0。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-13/doc-inirsuvy5397470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","FLHK","LNGR","MEDX","BK1574","IBBQ","159992","BK1161","520880","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529140","title":"重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529140","media":"新浪基金","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666529140?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:17","pubTimestamp":1789125420,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线,重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图:港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整?低位埋伏创新药,关注两大投资工具:港股通创新药ETF华宝:紧密跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,前十大权重股占比超七成,龙头属性突出,底层资产是港股,高弹性、T+0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhry5675751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","159316","BK1161","FLHK","520880","06978","BK1574","159992","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664231028","title":"创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!","url":"https://stock-news.laohu8.com/highlight/detail?id=2664231028","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664231028?lang=zh_cn&edition=full","pubTime":"2026-09-03 10:52","pubTimestamp":1788403920,"startTime":"0","endTime":"0","summary":"9月3日,港股创新药链继续活跃,创新药龙头公司领涨,石药集团、中国生物制药双双涨超4%。纯正创新药指数——恒生港股通创新药精选指数一度冲高逾2%,跟踪该指数的港股通创新药ETF华宝盘中再收半年线。中金公司提示,创新药较多公司进入临床数据验证阶段,值得自下而上关注。据统计,港股通创新药ETF华宝覆盖的48家创新药研发公司中,31家上半年实现盈利,归母净利同比正增长的有33家,占比近7成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-03/doc-iniqpkry1034045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1521","BK1161","LU1993786604.SGD","LU0314109678.HKD","LU1328277881.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","159992","BK1574","LNGR","LU0326950275.SGD","LU2039709279.SGD","IBBQ","LU0315179316.USD","159316","SG9999004220.SGD","LU1152091168.USD","LU1226288170.HKD","HK0000165453.HKD","BK1191","LU0140636845.USD","IE0008369823.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1152091754.HKD","FLHK","BK1515","IE00B031HY20.USD","MEDX","IE0008368742.USD","01093","520880","KURE","LU1226287792.SGD","LU0067412154.USD","LU1951186391.HKD","LU1960683339.HKD","06978","LU1008478684.HKD","LU1226287875.USD","LU0072913022.USD","LU1807302812.USD","LU1226287529.USD","LU1226288253.USD","IE00B5MMRT66.SGD","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039137","title":"【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039137?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:32","pubTimestamp":1787869958,"startTime":"0","endTime":"0","summary":"证券之星消息,8月27日,港股通创新药ETF华宝基金(520880)涨1.27%,成交额3.93亿元。当日份额减少了1.5亿份,最新份额为44.36亿份,近20个交易日份额减少6.62亿份。当日资金净流出3785.43万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.5亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.1%,近一个月超额回报为-0.06%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662992722","title":"创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!","url":"https://stock-news.laohu8.com/highlight/detail?id=2662992722","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662992722?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:20","pubTimestamp":1787800800,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝关注度持续升温。图:港股通创新药ETF华宝近6个月日K走势如何看待近期创新药行情?港股通创新药ETF华宝基金经理丰晨成最新解读来了,三个维度拆解行情逻辑。全链布局创新药,关注两大T+0交易利器:港股通创新药ETF华宝:被动跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,7成仓位押注研发龙头。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-27/doc-iniptnux9036538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","BK1161","LNGR","BK1574","FLHK","159992","IBBQ","MEDX","159316","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662502357","title":"【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662502357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662502357?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:32","pubTimestamp":1787697165,"startTime":"0","endTime":"0","summary":"证券之星消息,8月25日,港股通创新药ETF华宝基金(520880)涨1.1%,成交额4亿元。当日份额减少了7000万份,最新份额为46.96亿份,近20个交易日份额减少4.18亿份。当日资金净流出223.9万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.96亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.92%,近一个月超额回报为-0.07%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794754806118,"stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0861},{"period":"6month","weight":-0.0961},{"period":"1year","weight":-0.2995},{"period":"ytd","weight":-0.1687}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"港股通创新药ETF华宝,520880,港股通创新药ETF华宝股票,港股通创新药ETF华宝股票老虎,港股通创新药ETF华宝股票老虎国际,港股通创新药ETF华宝行情,港股通创新药ETF华宝股票行情,港股通创新药ETF华宝股价,港股通创新药ETF华宝股市,港股通创新药ETF华宝股票价格,港股通创新药ETF华宝股票交易,港股通创新药ETF华宝股票购买,港股通创新药ETF华宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}